학술논문

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
Document Type
Article
Source
In Kidney International Reports March 2023 8(3):499-506
Subject
Language
ISSN
2468-0249